I am BIO Podcast: Featuring UF Ventures Director Jackson Streeter
Recently, our very own Jackson Streeter was featured on the I Am BIO (Biotechnology Innovation Organization) Podcast. Hear how UF is spending over 1 billion dollars in research and how their work with AAV could help cure all types of genetic disorders.
New College Ranking of Technology Transfer Has a Surprise Number Two
It seems for every college, there’s a list about colleges – a ranking. This one, from a non-partisan think tank called Heartland Forward, isn’t so much a ranking as it is a research paper scoring how well and how often school take their considerable research prowess and transfer it into markets. It’s a research ranking. the second spot on this list that may raise an eyebrow – The University of Florida. The school reached this lofty post, the paper found, despite having a research budget ranked just 29th.
Exactech Announces Successful First Surgeries With Latest Instrumentation for Its Newton™ Balanced Knee Technology
UF startup Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today first surgeries leveraging the power of the Newton™ Knee, featuring new, user-friendly instrumentation and a modernized graphical user interface. With a rich array of pre-clinical data, the Newton Knee is at the forefront of Exactech’s focus to improve clinical outcomes by utilizing soft tissue balancing technology in total knee replacement patients
UF-Led Center Continues Fight Against Diseases Spread by Mosquitoes, Ticks
Established in 2016, the Southeast Regional Center of Excellence in Vector-Borne Disease: The Gateway Program (SECVBD) will continue its work for another five years, thanks to renewed funding from the Centers for Disease Control and Prevention (CDC). “The center is a team effort to help communities prevent, prepare and respond to vector-borne disease threats through applied research and education efforts. We look forward to continuing to inform these public health actions,” said Rhoel Dinglasan, the center’s director and a professor in the University of Florida College of Veterinary Medicine affiliated with the UF Emerging Pathogens Institute.
UF researchers discover new way to inhibit virus that causes COVID-19
When the virus that causes COVID-19 enters the body, it hijacks cellular proteins and suppresses the human inflammatory response, allowing the virus to spread. University of Florida researchers have discovered a novel way in the lab to fight rapidly evolving strains of coronaviruses by breaking that cycle.
Researchers Leverage AI To Identify Sepsis Within 12 Hours
Researchers at the University of Florida have created and are using a diagnostic tool that leverages artificial intelligence to identify a patient’s likelihood of developing sepsis — and how severe it will be — as soon as 12 hours after their hospital admission.
UF/IFAS Research on Crocodiles Provides Key Insights on Wildlife Aging
Scientists at the UF/IFAS Fort Lauderdale Research and Education Center (FLREC) contributed critical research over the last 40 years of American crocodiles to a global comparative study on longevity, aging and mortality in ectothermic tetrapods. The study, published in the journal Science, represents the first data compilation of its kind using 107 populations of 77 species from 98 research institutions. The study provides a comparative analysis of mortality in the wild – a missing piece of the puzzle in science until now.
Cannabix Technologies Participates in New Southern United States Study With Marijuana Breathalyzer Technology
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company is participating in a new comprehensive multi-analysis study of subjects under the influence of marijuana. The new study will work along side toxicologists and law enforcement officers in the southern United States.
UF Partners With CIA on Improving Cybersecurity
The university and the CIA have entered an agreement to study how artificial intelligence and machine learning applications (AIML) can be used to detect and deter malicious agents that infiltrate computer networks. The work will be carried out by researchers associated with UF’s Florida Institute for National Security.
CEO of UF Startup AxoGen is appointed to EyePoint Pharmaceuticals Board of Directors
EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Karen Zaderej to its Board of Directors. Ms. Zaderej is currently the President, Chief Executive Officer and Chair of the Board at UF Startup and Accelerate graduate AxoGen, Inc., and brings more than 35 years of biopharmaceutical and medical device experience to the role.
